secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2025-04-10T23:59:59+00:00
Accession:  0000950170-25-052679
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health regains Nasdaq minimum bid price compliance; stock continues listing
--------------------------------------------------------------------------------

- Received Nasdaq confirmation on April 4, 2025 that minimum bid price compliance is regained.
- Reverse stock split implemented on March 7, 2025 as required by Nasdaq Hearings Panel.
- Company had been notified of deficiency in June 2024 and received extension through panel decision.
- Common stock (TIVC) continues trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025052679/0000950170-25-052679-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025052679/tivc-20250404.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-052679

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer